Skip to main content
SpringerLink
Log in

Kribbeln, Schmerzen und Funktionseinbußen

Patient mit Small-Fiber-Neuropathie — das können Sie tun

  • FORTBILDUNG_ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Zusammenfassung

Eine Schädigung der kleinkalibrigen peripheren unmyelinisierten C-Fasern und der gering myelinisierten A-delta-Fasern (Small Fibers), z. B. durch Diabetes mellitus oder Gifte bzw. Medikamente, kann zu ganz unterschiedlichen Symptomen führen. Neben schmerzhaften Parästhesien beeinträchtigen dyshidrotische, kardiovaskuläre, urogenitale oder gastrointestinale Beschwerden die Lebensqualität nachhaltig. Verschaffen Sie sich einen Überblick darüber, was Sie für betroffene Patienten tun können.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Freeman R. Autonomic peripheral neuropathy. Lancet. 2005;365:1259–70

    Article  CAS  PubMed  Google Scholar 

  2. Siepmann T, Penzlin AI, Illigens BM. Autonomic neuropathies. Dtsch Med Wochenschr. 2013;138:1465–69

    Article  CAS  PubMed  Google Scholar 

  3. Vinik AI, Erbas T. Diabetic autonomic neuropathy. Handb Clin Neurol. 2013;117:279–94

    Article  PubMed  Google Scholar 

  4. Kiuru S, Matikainen E, Kupari M et al. Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci. 1994;126:40–8

    Article  CAS  PubMed  Google Scholar 

  5. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337:898–909

    Article  CAS  PubMed  Google Scholar 

  6. Arruda WO, Teive HA, Ramina R et al. Autonomic neuropathy in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 1989;52:539–40

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Axelrod FB. Hereditary sensory and autonomic neuropathies: familial dysautonomia and other HSANs. Clin Auton Res. 2002;12(suppl 1):12–4

    Google Scholar 

  8. Zochodne DW. Autonomic involvement in Guillain-Barré syndrome: a review. Muscle Nerve. 1994;17:1145–55

    Article  CAS  PubMed  Google Scholar 

  9. Tavee J, Zhou L. Small fiber neuropathy: A burning problem. Cleve Clin J Med. 2009;76:297–305

    Article  PubMed  Google Scholar 

  10. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care. 1978;1:168–88,252–63

    Article  Google Scholar 

  11. Maser RF, Mitchell BD, Vinik AI et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003;26:1895–1901

    Article  PubMed  Google Scholar 

  12. Auer-Grumbach M. Hereditary sensory and autonomic neuropathies. Handb Clin Neurol. 2013;115:893–906

    Article  PubMed  Google Scholar 

  13. Houlden H, Smith S, de Carvalho M et al. Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain. 2002;125:2681–90

    Article  PubMed  Google Scholar 

  14. Low PA, Dyck PJ, Okazaki H et al. The splanchnic autonomic outflow in amyloid neuropathy and Tangier disease. Neurology. 1981;31:461–63

    Article  CAS  PubMed  Google Scholar 

  15. Dyck PJ, Carney JA, Sizemore GW et al. Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis. Ann Neurol. 1979;6:302–14

    Article  CAS  PubMed  Google Scholar 

  16. Matikainen E, Juntunen J. Autonomic nervous system dysfunction in workers exposed to organic solvents. J Neurol Neurosurg Psychiatry. 1985;48:1021–24

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Auld RB, Bedwell SF. Peripheral neuropathy with sympathetic overactivity from industrial contact with acrylamide. Can Med Assoc J. 1967;96:652–54

    PubMed Central  CAS  PubMed  Google Scholar 

  18. LeQuesne PM, McLeod JG. Peripheral neuropathy following a single exposure to arsenic. J Neurol Sci. 1977;32:437–51

    Article  CAS  Google Scholar 

  19. Nordentoft T, Andersen EB, M ogensen PH. Initial sensorimotor and delayed autonomic neuropathy in acute thallium poisoning. Neurotoxicology. 1998;19:421–26

    CAS  PubMed  Google Scholar 

  20. LeWitt PA. The neurotoxicity of the rat poison vacor: a clinical study of 12 cases. N Engl J Med. 1980;302:73–7

    Article  CAS  PubMed  Google Scholar 

  21. Pearn J. Neurology of ciguatera. J Neurol Neurosurg Psychiatry. 2001;70:4–8

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Legha SS. Vincristine neurotoxicity: pathophysiology and management. Med Toxicol. 1986;1:421–27

    CAS  PubMed  Google Scholar 

  23. Boogerd W, ten Bokkel Huinink WW, Dalesio O et al. Cisplatin induced neuropathy: central, peripheral and autonomic nerve involvement. J Neuro-Oncol. 1990;9:255–63

    Article  CAS  Google Scholar 

  24. Freeman R, Roberts MS, Friedman LS et al. Autonomic function and human immunodeficiency virus infection. Neurology. 1990 40:575–80

    Article  CAS  PubMed  Google Scholar 

  25. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366:1653–66

    Article  CAS  PubMed  Google Scholar 

  26. Figueroa JJ, Dyck PJ, Laughlin RS et al. Autonomic dysfunction in chronicinflammatory demyelinating polyradiculoneuropathy. Neurology 2012;78:702–8

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Hoyle C, Ewing DJ, Parker AC. Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann Rheum Dis. 1985;44:420–24

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Winkler AS, Dean A, Hu M et al. Phenotypic and neuropathologic heterogeneity of anti-Hu antibody-related paraneoplastic syndrome presenting with progressive dysautonomia: report of two cases. Clin Auton Res. 2001;11:115–8

    Article  CAS  PubMed  Google Scholar 

  29. Siepmann T, Illigens BM, Reichmann H et al. Axon-reflex based nerve fiber function assessment in the detection of autonomic neuropathy. Der Nervenarzt. 2014; 85:1309–14

    Article  CAS  PubMed  Google Scholar 

  30. Moloney NA, Hall TM, Doody CM. Reliability of thermal quantitative sensory testing: a systematic review. J Rehabil Res Dev. 2012;49:191–207

    Article  PubMed  Google Scholar 

  31. Chong PS, Cros DP. Technology literature review: quantitative sensory testing. Muscle Nerve. 2004;29:734–47

    Article  PubMed  Google Scholar 

  32. Berghoff M, Kathpal M, Kilo S et al. Vascular and neural mechanisms of ACh- mediated vasodilation in the forearm cutaneous microcirculation. J Appl Physiol. 2002;92:780–8

    Article  CAS  PubMed  Google Scholar 

  33. Kilo S, Berghoff M, Hilz M et al. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology. 2000;54:1246–52

    Article  CAS  PubMed  Google Scholar 

  34. Benarroch EE, Low PA. The acetylcholine-induced flare response in evaluation of small fiber dysfunction. Ann Neurol. 1991;29:590–5

    Article  CAS  PubMed  Google Scholar 

  35. Low P, Neumann C, Dyck PJ et al. Evaluation of skin vasomotor reflexes by using laser Doppler velocimetry. Mayo Clin Proc. 1983;58:583–92

    CAS  PubMed  Google Scholar 

  36. Low VA, Sandroni P, Fealey RD et al. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve. 2006;34:57–61

    Article  PubMed  Google Scholar 

  37. Illigens BM, Gibbons CH. Sweat testing to evaluate autonomic function. Clin Auton Res. 2009;19:79–87

    Article  PubMed Central  PubMed  Google Scholar 

  38. Vlcková-Moravcová E, Bednarík J, Dusek L et al. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve. 2008;37:50–60

    Article  PubMed  Google Scholar 

  39. Wang N, Gibbons CH. Skin biopsies in the assessment of the autonomic nervous system. Handb Clin Neurol. 2013;117:371–8

    Article  PubMed  Google Scholar 

  40. Illigens BM, Siepmann T, Roofeh J et al. Laser-Doppler Imaging in the Detection of Peripheral Neuropathy. Auton Neurosci. 2013;177:286–90

    Article  PubMed Central  PubMed  Google Scholar 

  41. Gibbons CH, Illigens BM, Centi J et al. QDIRT: quantitative direct and indirect test of sudomotor function. Neurology. 2008;70:2299–304

    Article  PubMed Central  PubMed  Google Scholar 

  42. Siepmann T, Gibbons C, Lafo J et al. Quantitative Pilomotor Axon-Reflex Test - A Novel Test of Pilomotor Function. Arch Neurol. 2012;6:1–5

    Google Scholar 

  43. Patterson D, Abell T, Rothstein R et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol. 1999;94:1230–4

    CAS  PubMed  Google Scholar 

  44. Siepmann T, Penzlin AI, Illigens BMW. Autonomic neuropathy — diagnosis and evidence based treatment. Dtsch Med Wochenschr. 2013;138:1529–32

    Article  CAS  PubMed  Google Scholar 

  45. Webb DJ, Muirhead GJ, Wulff M et al. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol. 2000;36:25–31

    Article  CAS  PubMed  Google Scholar 

  46. Caremel R, Cornu JN, Kerdraon J et al. Drug therapy of bladder dysfunction. Prog Urol 2013;23:1271–86

    Article  CAS  PubMed  Google Scholar 

  47. Kaufmann H, Freeman R, Biaggioni I et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 22;83:328–35

  48. Baron R. Pharmakologisch nicht interventionelle Therapie chronisch neuropathischer Schmerzen. Aus: Hans-Christoph Diener, Christian Weimar (Hrsg.) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart, 2012;771–83.

  49. Bril V, England J, Franklin GM et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011;7: 1758–65.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Neurologie, Universitätsklinik Carl Gustav Carus, Technische Universität Dresden, Fetscherstraße 74,, D-01307, Dresden, Deutschland

    Timo Siepmann

  2. Oxford Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, Oxfordshire, UK

    Timo Siepmann

  3. Dresden, Deutschland

    Ana Isabel Penzlin, Elka Frenz,  Kristian Barlinn,  Kerstin Weidner,  Tjalf Ziemssen &  Heinz Reichmann

  4. Harvard Medical School, Boston, Massachusetts, USA

    Ben Min-Woo Illigens

Authors
  1. Timo Siepmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Isabel Penzlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elka Frenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kristian Barlinn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kerstin Weidner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tjalf Ziemssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Heinz Reichmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ben Min-Woo Illigens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timo Siepmann.

Additional information

This article is part of a supplement not sponsored by the industry.

Interessenkonflikt

Die Autoren erklären, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließ. Sie legen folgende potenzielle Interessenkonflikte offen: keine.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Siepmann, T., Penzlin, A.I., Frenz, E. et al. Patient mit Small-Fiber-Neuropathie — das können Sie tun. MMW - Fortschritte der Medizin 157 (Suppl 3), 60–66 (2015). https://doi.org/10.1007/s15006-015-3300-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-015-3300-2

Keywords

Search

Navigation